Article Details
Retrieved on: 2025-03-20 13:26:13
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca declined to comment without detailed clinical data on claims by Chinese makers of a competing experimental lung cancer drug.
Article found on: in.benzinga.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here